Nucleotide Sequences
QTLs in Region (mRatBN7.2)
RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | 2312673 | Scl63 | Serum cholesterol level QTL 63 | 0.001 | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 3 | 98535255 | 168026850 | Rat | 1578653 | Vnigr3 | Vascular neointimal growth QTL 3 | 3.1 | artery morphology trait (VT:0002191) | artery neointimal hyperplastic lesion area (CMO:0001414) | 3 | 130656562 | 169034231 | Rat | 1598877 | Bp285 | Blood pressure QTL 285 | 1.5 | 0.03 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 3 | 120538241 | 165538241 | Rat | 2302373 | Gluco39 | Glucose level QTL 39 | 5.01 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 3 | 98535386 | 161695835 | Rat | 1298068 | Bp167 | Blood pressure QTL 167 | 0.004 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 3 | 141074471 | 169034231 | Rat | 70216 | Cm14 | Cardiac mass QTL 14 | 2.1 | heart mass (VT:0007028) | heart wet weight (CMO:0000069) | 3 | 31172320 | 163586636 | Rat | 2292591 | Esta4 | Estrogen-induced thymic atrophy QTL 4 | thymus mass (VT:0004954) | thymus wet weight (CMO:0000855) | 3 | 47233211 | 147415807 | Rat | 2298477 | Eau4 | Experimental allergic uveoretinitis QTL 4 | 0.0011 | uvea integrity trait (VT:0010551) | experimental autoimmune uveitis score (CMO:0001504) | 3 | 137398739 | 169034231 | Rat | 61335 | Bp20 | Blood pressure QTL 20 | 3 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 3 | 141339236 | 155617360 | Rat | 1581568 | Rf53 | Renal function QTL 53 | urine total protein amount (VT:0000032) | urine protein excretion rate to body weight ratio (CMO:0001099) | 3 | 56395968 | 161299569 | Rat | 1331726 | Bp208 | Blood pressure QTL 208 | 3.129 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 3 | 141339013 | 162184794 | Rat | 1578754 | Stresp16 | Stress response QTL 16 | 4 | 0.001 | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 3 | 112681431 | 157681431 | Rat | 1300173 | Rf11 | Renal function QTL 11 | 3.38 | renal blood flow trait (VT:2000006) | absolute change in renal blood flow rate (CMO:0001168) | 3 | 121056165 | 145956249 | Rat | 9589106 | Insul23 | Insulin level QTL 23 | 13.86 | 0.001 | blood insulin amount (VT:0001560) | plasma insulin level (CMO:0000342) | 3 | 131635904 | 169034231 | Rat | 10755461 | Coatc16 | Coat color QTL 16 | coat/hair pigmentation trait (VT:0010463) | pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) | 3 | 122438700 | 167438700 | Rat | 8662816 | Vetf4 | Vascular elastic tissue fragility QTL 4 | 4 | renal artery integrity trait (VT:0010642) | number of ruptures of the internal elastic lamina of the renal arteries (CMO:0002563) | 3 | 59242096 | 157323038 | Rat | 1559282 | Emca5 | Estrogen-induced mammary cancer QTL 5 | 3.9 | mammary gland integrity trait (VT:0010552) | percentage of study population developing mammary tumors during a period of time (CMO:0000948) | 3 | 43827364 | 169034231 | Rat | 2303620 | Vencon4 | Ventilatory control QTL 4 | 3.9 | respiration trait (VT:0001943) | tidal volume (CMO:0000222) | 3 | 127162703 | 168026850 | Rat | 631841 | Niddm39 | Non-insulin dependent diabetes mellitus QTL 39 | 3.36 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 3 | 94856903 | 159898684 | Rat | 1576306 | Schws3 | Schwannoma susceptibility QTL 3 | 0.001 | nervous system integrity trait (VT:0010566) | percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) | 3 | 118839124 | 163839124 | Rat | 619618 | Rf3 | Renal disease susceptibility QTL 3 | 6.5 | 0.001 | urine albumin amount (VT:0002871) | urine albumin excretion rate to body weight ratio (CMO:0001270) | 3 | 107693393 | 152693393 | Rat | 1300159 | Kidm4 | Kidney mass QTL 4 | 3.83 | kidney mass (VT:0002707) | right kidney wet weight to body weight ratio (CMO:0001953) | 3 | 121056165 | 157309487 | Rat | 5686842 | Rf59 | Renal function QTL 59 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 3 | 140069424 | 146976080 | Rat | 631673 | Iddm13 | Insulin dependent diabetes mellitus QTL 13 | 1.3 | 0.663 | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 3 | 130193298 | 161695983 | Rat | 2312659 | Slep7 | Serum leptin concentration QTL 7 | 0.001 | blood leptin amount (VT:0005667) | serum leptin level (CMO:0000780) | 3 | 98535255 | 168026850 | Rat | 2301971 | Cm71 | Cardiac mass QTL 71 | 4.63 | heart left ventricle mass (VT:0007031) | heart left ventricle weight (CMO:0000776) | 3 | 41874578 | 155617519 | Rat | 2301970 | Bw81 | Body weight QTL 81 | 5.19 | body mass (VT:0001259) | body weight (CMO:0000012) | 3 | 41874578 | 155617519 | Rat | 1581546 | Pur13 | Proteinuria QTL 13 | 2.93 | 0.0335 | urine total protein amount (VT:0000032) | urine protein excretion rate (CMO:0000759) | 3 | 78196190 | 146592722 | Rat | 1578656 | Vnigr2 | Vascular neointimal growth QTL 2 | 4.2 | artery morphology trait (VT:0002191) | lesioned artery residual lumen area (CMO:0001417) | 3 | 130656562 | 169034231 | Rat | 8552952 | Pigfal13 | Plasma insulin-like growth factor 1 level QTL 13 | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 3 | 138799500 | 169034231 | Rat | 631541 | Bp81 | Blood pressure QTL 81 | 4 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 3 | 124122556 | 169034231 | Rat | 2312670 | Bw94 | Body weight QTL 94 | 0.01 | inguinal fat pad mass (VT:0010424) | inguinal fat pad weight to body weight ratio (CMO:0001253) | 3 | 98535255 | 168026850 | Rat | 2293087 | Iddm27 | Insulin dependent diabetes mellitus QTL 27 | 2.68 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 3 | 97551417 | 147415807 | Rat | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Information